SCHEMBL9945010

SCHEMBL9945010

CC(C)(O)C1(Nc2cc(Cl)c(C(=O)N[C@H]3CC[C@H](C)CC3)cc2[N+](=O)[O-])CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.45
HPGD P15428 3/20 0.40
RAB9A P51151 5/20 0.37
NPC1 O15118 4/20 0.37
TAS1R3 Q7RTX0 1/20 0.36
TAS1R1 Q7RTX1 1/20 0.36
TAS1R2 Q8TE23 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.35
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA3 P07451 1/20 0.35
CA4 P22748 1/20 0.35
CA6 P23280 1/20 0.35
CA5A P35218 1/20 0.35
CA7 P43166 1/20 0.35
CA9 Q16790 1/20 0.35
CA13 Q8N1Q1 1/20 0.35
CA14 Q9ULX7 1/20 0.35
CA5B Q9Y2D0 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9945011 0.84 ALDH1A1 (0.37) ALDH1A1RAB9ANPC1TAS1R3TAS1R1
SCHEMBL9944747 0.82 ALDH1A1 (0.53) ALDH1A1HPGDRAB9ANPC1TAS1R3
SCHEMBL9945003 0.82 ALDH1A1 (0.53) ALDH1A1HPGDRAB9ANPC1TAS1R3
SCHEMBL9945014 0.82 ALDH1A1 (0.47) ALDH1A1HPGDRAB9ANPC1TAS1R3
SCHEMBL9944880 0.80 ALDH1A1 (0.50) ALDH1A1HPGDRAB9ANPC1TAS1R3
SCHEMBL12494909 0.77 ALDH1A1 (0.59) ALDH1A1HPGDRAB9ANPC1SMN1; SMN2
SCHEMBL9945024 0.77 ALDH1A1 (0.47) ALDH1A1HPGDRAB9ANPC1TAS1R3
SCHEMBL12494332 0.75 ALDH1A1 (0.54) ALDH1A1HPGDRAB9ANPC1SMN1; SMN2
SCHEMBL12494815 0.75 ALDH1A1 (0.54) ALDH1A1HPGDRAB9ANPC1SMN1; SMN2
SCHEMBL12494724 0.75 ALDH1A1 (0.66) ALDH1A1HPGDRAB9ANPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8674113-B2 Compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-03-18 US disclosed
US-20120149676-A1 NOVEL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149676-A1 NOVEL COMPOUNDS PTGS1, PTGER1, PTGES ALDH1A1 126/4885HPGD 20/4885RAB9A 1033/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.